To generate long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies, to include, but not limited to, pharmaceutical, biotechnology, medical device and healthcare services companies.
Management group
Polar Capital Holdings
Launch date
United Kingdom
Fund manager
David Pinniger, James Douglas, Deane Donnigan, Gareth Powell
Dividend frequency
Wind-up provisions
In the absence of any prior proposals, the Articles of Association of the Company require the Directors to put forward at the first Annual General Meeting following 1 March 2025 a special resolution to place the Company into voluntary liquidation. The voting on that resolution will be enhanced such that, provided any single vote is cast in favour, the resolution will be passed.
Share type Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
Ordinary Share 459.61 484.35 379.00 399.40 -5.11 0 0.58 Feb, Aug 0.87 (30/09/2023)


Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
01/02/2024 29/02/2024 1.200 No 2023
03/08/2023 31/08/2023 1.000 No 2023

Performance (%)

Return type 1 year 3 years 5 years 10 years
Polar Capital Global Healthcare Share price total return 19.0 41.7 75.2 185.6
Biotechnology & Healthcare AIC sector Share price total return N/A N/A N/A N/A

Share structure

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Polar Capital Glb Healthcare Ord Total 222,866 4,186,605 46,620,607 251,404,650
Polar Capital Glb Healthcare Ord Average N/A 195,381 184,226 199,240

Traded values (m)

  Yesterday 1 month 1 year 5 years
Polar Capital Glb Healthcare Ord Total 0.84 15.63 161.13 710.86
Polar Capital Glb Healthcare Ord Average N/A 0.73 0.64 0.56

Trading details

ISIN TIDM Traded currency Stock exchange
GB00B6832P16 PCGH GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange

Top holdings

Data as at : 31/05/2024

Investment % of total assets
UnitedHealth Group Inc 7.9
Eli Lilly and Co 7.6
Zealand Pharma A/S 5.5
AbbVie Inc 5.2
Novartis AG Registered Shares 5.0
UCB SA 4.2
CSL Ltd 4.1
Intuitive Surgical Inc 3.9
Elevance Health Inc 3.8
Sanofi SA 3.6

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.